Your browser doesn't support javascript.
loading
The challenges for implementing Good Clinical Practices in the bioanalytical laboratory: a discussion paper from the European Bioanalysis Forum.
Timmerman, Philip; Ivanova, Tsvetelina; Arfvidsson, Cecilia; Barfield, Matthew; Bove, Floris; Brown, Lea Dalby; Goodman, Jo; McDougall, Stuart; Monk, Lee; White, Steve.
Afiliação
  • Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, Brussels, 1000, Belgium.
  • Ivanova T; Quality & Compliance, Comac Medical, Sofia, 1404, Bulgaria.
  • Arfvidsson C; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Barfield M; Roche Innovation Center Welwyn, Roche Pharma Research & Early Development, Welwyn Garden City, Hertfordshire, AL7 1TW, UK.
  • Bove F; J&J Innovative Medicine, Quality Assurance, Beerse, 2340, Belgium.
  • Brown LD; Novo Nordisk A/S, Non-clinical & Clinical Assay Sciences, Novo Nordisk Park, Maaløv, DK-2760, Denmark.
  • Goodman J; AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, Cambridge, CB21 6GH, UK.
  • McDougall S; Quotient Sciences, Bioanalytical Services, Taylor Drive, Alnwick, Northumberland, NE66 2DH, UK.
  • Monk L; Global Quality Assurance, UCB Biopharma UK, Slough, SL1 3WE, UK.
  • White S; GSK, IVIVT-BIB, Gunnells Wood Road, Stevenage, SG1 2NY, UK.
Bioanalysis ; 2024 Mar 26.
Article em En | MEDLINE | ID: mdl-38530219
ABSTRACT
This manuscript reports back from the discussion in the European Bioanalysis Forum community on the challenges observed when implementing Good Clinical Practices in the bioanalytical laboratory. It is not intended to challenge any regulatory requirements but to open a discussion on where the bioanalytical community sees ambiguities on implementing Good Clinical Practices or areas where expectations are either felt not being owned by Bioanalysis or where Good Clinical Practices requirements are at risk of getting contaminated with requirements originating from Good Laboratory Practices. In addition to this, the discussions focused on three additional main challenges the informed consent withdrawal, expedited reporting of unexpected results and the risk-based approach to quality management, The European Bioanalysis Forum community is continuing discussions, but already this manuscript should help to appreciate the challenges and to try and resolve them, involving all stakeholders.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article